145 related articles for article (PubMed ID: 33174007)
1. Endothelial cell‑derived CCL15 mediates the transmigration of fibrocytes through the CCL15‑CCR1 axis in vitro.
Pang N; Lin Z; Wang X; Xu L; Xu X; Huang R; Li X; Li X; Li J
Mol Med Rep; 2020 Dec; 22(6):5339-5347. PubMed ID: 33174007
[TBL] [Abstract][Full Text] [Related]
2. Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis.
Inamoto S; Itatani Y; Yamamoto T; Minamiguchi S; Hirai H; Iwamoto M; Hasegawa S; Taketo MM; Sakai Y; Kawada K
Clin Cancer Res; 2016 Jan; 22(2):492-501. PubMed ID: 26341919
[TBL] [Abstract][Full Text] [Related]
3. Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.
Yamamoto T; Kawada K; Itatani Y; Inamoto S; Okamura R; Iwamoto M; Miyamoto E; Chen-Yoshikawa TF; Hirai H; Hasegawa S; Date H; Taketo MM; Sakai Y
Clin Cancer Res; 2017 Feb; 23(3):833-844. PubMed ID: 27492974
[TBL] [Abstract][Full Text] [Related]
4. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.
Gao Y; Zhou Z; Lu S; Huang X; Zhang C; Jiang R; Yao A; Sun B; Wang X
Stem Cells; 2016 Apr; 34(4):1112-22. PubMed ID: 26763650
[TBL] [Abstract][Full Text] [Related]
5. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
6. CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.
Liu LZ; Zhang Z; Zheng BH; Shi Y; Duan M; Ma LJ; Wang ZC; Dong LQ; Dong PP; Shi JY; Zhang S; Ding ZB; Ke AW; Cao Y; Zhang XM; Xi R; Zhou J; Fan J; Wang XY; Gao Q
Hepatology; 2019 Jan; 69(1):143-159. PubMed ID: 30070719
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.
Escher SE; Forssmann U; Frimpong-Boateng A; Adermann K; Vakili J; Sticht H; Detheux M
J Pept Res; 2004 Jan; 63(1):36-47. PubMed ID: 14984572
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo.
Hwang J; Kim CW; Son KN; Han KY; Lee KH; Kleinman HK; Ko J; Na DS; Kwon BS; Gho YS; Kim J
FEBS Lett; 2004 Jul; 570(1-3):47-51. PubMed ID: 15251437
[TBL] [Abstract][Full Text] [Related]
9. Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1.
Sanchez J; Lane JR; Canals M; Stone MJ
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096719
[TBL] [Abstract][Full Text] [Related]
10. CCL15/CCR1 axis is involved in hepatocellular carcinoma cells migration and invasion.
Li Y; Wu J; Zhang P
Tumour Biol; 2016 Apr; 37(4):4501-7. PubMed ID: 26501423
[TBL] [Abstract][Full Text] [Related]
11. CC-chemokine CCL15 expression and possible implications for the pathogenesis of IgE-related severe asthma.
Shimizu Y; Dobashi K
Mediators Inflamm; 2012; 2012():475253. PubMed ID: 23258953
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic activation of alternative CCR1 ligands in inflammation.
Berahovich RD; Miao Z; Wang Y; Premack B; Howard MC; Schall TJ
J Immunol; 2005 Jun; 174(11):7341-51. PubMed ID: 15905581
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of CCL15 expression and monocyte adhesion to endothelial cells (ECs) after hypoxia/reoxygenation and induction of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs.
Park KH; Lee TH; Kim CW; Kim J
J Immunol; 2013 Jun; 190(12):6550-8. PubMed ID: 23690481
[TBL] [Abstract][Full Text] [Related]
14. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1.
Nardelli B; Tiffany HL; Bong GW; Yourey PA; Morahan DK; Li Y; Murphy PM; Alderson RF
J Immunol; 1999 Jan; 162(1):435-44. PubMed ID: 9886417
[TBL] [Abstract][Full Text] [Related]
16. Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells.
Yin X; Han S; Song C; Zou H; Wei Z; Xu W; Ran J; Tang C; Wang Y; Cai Y; Hu Q; Han W
Cell Oncol (Dordr); 2019 Aug; 42(4):459-475. PubMed ID: 31001733
[TBL] [Abstract][Full Text] [Related]
17. Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis.
Hwang J; Son KN; Kim CW; Ko J; Na DS; Kwon BS; Gho YS; Kim J
Cytokine; 2005 Jun; 30(5):254-63. PubMed ID: 15927850
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene.
Bosco MC; Puppo M; Santangelo C; Anfosso L; Pfeffer U; Fardin P; Battaglia F; Varesio L
J Immunol; 2006 Aug; 177(3):1941-55. PubMed ID: 16849508
[TBL] [Abstract][Full Text] [Related]
19. Role of human LZIP in differential activation of the NF-kappaB pathway that is induced by CCR1-dependent chemokines.
Jang SW; Kim YS; Lee YH; Ko J
J Cell Physiol; 2007 Jun; 211(3):630-7. PubMed ID: 17192849
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells.
Parker LC; Whyte MK; Vogel SN; Dower SK; Sabroe I
J Immunol; 2004 Apr; 172(8):4977-86. PubMed ID: 15067079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
